XENE Working Capital Ratio

Xenon Pharmaceuticals Inc · Working Capital Ratio

XENE logo

XENE Working Capital Ratio

Latest reported52.85%
XENE FY Working Capital Ratio (65.57% → 52.85%)
High-resolution chart · PNG

XENE working capital ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Xenon Pharmaceuticals Inc Working Capital Ratio — Annual fiscal periods
Period endingWorking Capital Ratio
52.8545%
75.134%
64.0226%
76.5894%
95.2258%
88.274%
68.713%
95.8261%
88.3285%
92.1051%
90.8286%
80.8255%
58.1166%
65.5667%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.